close

Enter

Log in using OpenID

Sevoflurane, Isoflurane and Desflurane Market Size, Market Share, Application Analysis, Regional Outlook, Growth, Trends, Competitive Scenario And Forecasts, 2012 To 2020

embed
Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies and children. Sevoflurane is ideal for patients with asthma or sensitive air passages.
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Sevoflurane, Isoflurane and Desflurane Market Size, Market
Share, Application Analysis, Regional Outlook, Growth,
Trends, Competitive Scenario And Forecasts, 2012 To 2020
Overview
The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in
comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used
by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are
very strong and cost less, with minimum damage to the ozone layer.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/sevofluraneisoflurane-desflurane-industry/
Market Drivers
One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market
includes cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer,
orthopedic, spinal and gastro-intestinal cases have also furthered the market. Cataract surgery is a
major contributor to the global market and will need a higher production of these chemicals.
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Growing accidents and emergency cases also add income to the inhalation anesthesia market. Universal
insurance coverage as well as constant improvements in medical infrastructure also ensure the
development of the sevoflurane, isoflurane and desflurane market. These agents are administered to
patients prior surgery, making the induction of general anesthesia much simpler.
A major factor hindering the market is the quantity of CO2 released in the environment, leading to
global warming. Actually, only about 5 percent of the gases are consumed by patients. The rest are
released into the atmosphere and make it unhealthy. The most practical solution for this problem is the
anesthetic recycling of products used during the administration of general anesthesia.
Products Overview
Sevoflurane
Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies
and children. Sevoflurane is ideal for patients with asthma or sensitive air passages. But its side-effects
include delirium and agitation. It can be given quickly without the use of intravenous instruments.
Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and desflurane market by
2022. The agent is expected to exceed USD 1 billion by the same year. It’s widely utilized for being lowpriced and possessing therapeutic benefits.
Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/268
Isoflurane
Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously,
relaxes the muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long
durations during surgery. It is expected to register a CAGR of about 10% by 2022.
Desflurane
Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth of isoflurane.
Desflurane cannot be administered orally and requires an electrically heated dispenser to distribute the
vapor. It is mostly administered to bariatric patients and in cases of surgeries lasting for short durations.
Regional Overview
The United States has a large geriatric population. This has led the region of North America to occupy
the biggest share in the worldwide inhalation anesthesia market in 2014. Surgical ambulatory and
inpatient procedures are the driving factors of North America.
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of chronic diseases and
need for better health infrastructure in the region. Medical tourism combined with insurance coverage
will play a huge role in sustaining the growth of the sevoflurane, isoflurane and desflurane market.
Browse All Pharmaceuticals Industry Research Related Reports @
http://www.hexaresearch.com/research-category/pharmaceuticals-industry/
Key Players
The market is currently dominated by AbbVie and Baxter International. However, it can expect strong
competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises.
Piramal Enterprises currently has isoflurane and sevoflurane production underway. It will manufacture
generic desflurane by 2016. AbbVie has sevoflurane and isoflurane under production. Baxter
International is the only one that manufactures all the three products.
Anesthesia has some unhealthy effects. The recycling companies of Deltasorb Technologies and
Anesthetic Gas Reclamation reprocess anesthesia containers and gases from hospital vents. Rising
investments by the aforementioned players would also accelerate the sales of the sevoflurane,
isoflurane and desflurane market.
Table of Contents

Executive Summary & Digital Transformation industry critical success factors

Industry Outlook

Industry Dynamics

Digital Transformation Market drivers

Digital Transformation Market restraints

Digital Transformation Key Market Opportunities

Digital Transformation Porters Analysis

Digital Transformation - PESTEL Analysis

Digital Transformation - Company Market Share Analysis

Digital Transformation Application Outlook

Digital Transformation Regional Outlook
Hexa Research Inc.
Industry Research,Custom Research & Consulting

Digital Transformation Company profiles

Research Methodology

Research scope & assumptions

List of data sources
Browse Full Report @ http://www.hexaresearch.com/research-report/sevoflurane-isofluranedesflurane-industry/
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/
Visit our Blogs: http://hexaresearchinc.blogspot.com/
Author
maria10lee
maria10lee135   documents Email
Document
Category
Uncategorized
Views
8
File Size
376 KB
Tags
sevoflurane
1/--pages
Report inappropriate content